Schmidt-Erfurth U - Search Results

1

Retinal and Corneal Neurodegeneration and Their Association with Systemic Signs of Peripheral Neuropathy in Type 2 Diabetes.

Hafner J, Zadrazil M, Grisold A, Ricken G, Krenn M, Kitzmantl D, Pollreisz A, Gleiss A, Schmidt-Erfurth U. Hafner J, et al. Am J Ophthalmol. 2020 Jan;209:197-205. doi: 10.1016/j.ajo.2019.09.010. Epub 2019 Sep 19. Am J Ophthalmol. 2020. PMID: 31542341

2

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Schmidt-Erfurth U, et al. Ophthalmology. 2005 Dec;112(12):2061-9. doi: 10.1016/j.ophtha.2005.09.007. Ophthalmology. 2005. PMID: 16325705

3

Topographic angiography and optical coherence tomography: a correlation of imaging characteristics.

Ahlers C, Michels S, Elsner H, Birngruber R, Pruente C, Schmidt-Erfurth U. Ahlers C, et al. Eur J Ophthalmol. 2005 Nov-Dec;15(6):774-81. doi: 10.1177/112067210501500619. Eur J Ophthalmol. 2005. PMID: 16329065

4

Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone.

Michels S, Aue A, Simader C, Geitzenauer W, Sacu S, Schmidt-Erfurth U. Michels S, et al. Am J Ophthalmol. 2006 Feb;141(2):396-398. doi: 10.1016/j.ajo.2005.08.046. Am J Ophthalmol. 2006. PMID: 16458709

5

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U. Bolz M, et al. Br J Ophthalmol. 2007 Jun;91(6):785-9. doi: 10.1136/bjo.2006.102467. Epub 2006 Oct 18. Br J Ophthalmol. 2007. PMID: 17050580 Free PMC article. Clinical Trial.

6

Human macula investigated in vivo with polarization-sensitive optical coherence tomography.

Pircher M, Götzinger E, Findl O, Michels S, Geitzenauer W, Leydolt C, Schmidt-Erfurth U, Hitzenberger CK. Pircher M, et al. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5487-94. doi: 10.1167/iovs.05-1589. Invest Ophthalmol Vis Sci. 2006. PMID: 17122140

7

Functional macular mapping in patients with vitreomacular pathologic features before and after surgery.

Richter-Mueksch S, Vécsei-Marlovits PV, Sacu SG, Kiss CG, Weingessel B, Schmidt-Erfurth U. Richter-Mueksch S, et al. Am J Ophthalmol. 2007 Jul;144(1):23-31. doi: 10.1016/j.ajo.2007.03.045. Epub 2007 May 23. Am J Ophthalmol. 2007. PMID: 17509512

8

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U. Stifter E, et al. Am J Ophthalmol. 2007 Dec;144(6):886-892. doi: 10.1016/j.ajo.2007.07.034. Epub 2007 Oct 4. Am J Ophthalmol. 2007. PMID: 17916314

9

Randomized multicenter trial of more intense and standard early verteporfin treatment of neovascular age-related macular degeneration.

Schmidt-Erfurth U, Sacu S; Early Retreatment Study Group. Schmidt-Erfurth U, et al. Ophthalmology. 2008 Jan;115(1):134-40. doi: 10.1016/j.ophtha.2007.02.033. Ophthalmology. 2008. PMID: 18166408 Clinical Trial.

10

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U. Weigert G, et al. Br J Ophthalmol. 2008 Mar;92(3):356-60. doi: 10.1136/bjo.2007.125823. Br J Ophthalmol. 2008. PMID: 18303156 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters